KYNTRA BIO, INC. (KYNB) › Total LiabilitiesKYNTRA BIO, INC. (KYNB) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $242.85M2015: $273.75M2016: $294.44M2017: $350.91M2018: $352.13M2019: $321.99M2020: $385.39M2021: $544.71M2022: $611.57M2023: $585.73M2024: $398.16M2025: $115.12M$115.12M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$115.12M-71.1%2024$398.16M-32.0%2023$585.73M-4.2%2022$611.57M+12.3%2021$544.71M+41.3%2020$385.39M+19.7%2019$321.99M-8.6%2018$352.13M+0.3%2017$350.91M+19.2%2016$294.44M+7.6%2015$273.75M+12.7%2014$242.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share